Estradiol/progesterone - Innotesto

Drug Profile

Estradiol/progesterone - Innotesto

Alternative Names: Gynadiol

Latest Information Update: 12 Jan 2016

Price : $50

At a glance

  • Originator INNOTESTO bvba
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Menopausal syndrome

Most Recent Events

  • 12 Jan 2016 Phase-I clinical trials in Menopausal syndrome in Belgium (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top